Back to search
Macular Pigmentation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Macular Pigmentation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Macular Pigmentation trials you may qualify forBackground: The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imagin…
Background: Age-related macular degeneration is a common eye disease in people over 50. The "dry" form of the disease can worsen into geographic atrophy, causi…
The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims t…
Hypopigmented skin changes are commonly encountered by dermatologists. A new dermatological entity was identified as scattered, hypopigmented oval-shaped macule…
The proposed clinical investigation wants primary to validate the safety of the innovative light therapy approach and in second priority provide insight and con…
The goal of this clinical study is to evaluate the safety and efficacy of novel stem cell formulation in patients having Geographic Atrophy (GA) Secondary to Dr…
The purpose of this study is to understand the role of nutrition and its effects on the eye and other tissues. The investigators propose to study this by valida…
The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-derived retinal pigment epithelial (RPE) cel…
The purpose of this study is to is to evaluate the occurrence of late onset (i.e., greater than 5 years after treatment) adverse events of special interest (AES…